Vepsitamab (AMG 199) 是一种抗MUC17/CD3BiTE 抗体，可以结合 T 细胞上的 CD3 和肿瘤细胞上表达的 MUC17，介导重定向的肿瘤细胞裂解，并诱导 T 细胞活化和增殖。
| 生物活性 | Vepsitamab (AMG 199) is an anti-MUC17/CD3BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumorcell lysis, and induces T cell activation and proliferation[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
